Bafna Pharmaceuticals Limited (BAFNAPH.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.59B |
| Enterprise Value | 2.94B |
| P/E Ratio | 73.69 |
| PEG Ratio | -12.86 |
| Price/Sales Ratio | 3.97 |
| Price/Book Ratio | 6.31 |
| Enterprise/Revenue | 4.21 |
| Enterprise/EBITDA | 37.24 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0.08 |
AD
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 1.51B |
| Revenue/Share | 57.72 |
| Gross Profit | 201.42M |
| EBITDA | 207.04M |
| Net Income | 111M |
| Diluted EPS | 4.69 |
Balance Sheet
| Total Cash | 20.25M |
| Total Cash/Share | 0.81 |
| Total Debt | 374.33M |
| Total Debt/Equity | 0.39 |
| Current Ratio | 1.57 |
| Book Value Per Share | 38.41 |
Price History
| 52-Week Change | 153.19 |
| 52-Week High | 290.7 |
| 52-Week Low | 91.2 |
| Moving Average 50 Days | 224.37 |
| Moving Average 200 Days | 157.53 |
Statistics
| Average Volume | 27,277 |
| Shares Outstanding | 23.66M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | August 26, 2019 |
AD
